Every DEF 14A that Healthcare Triangle Inc (HCTI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HCTI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCTI filings page.
Healthcare Triangle, Inc. is holding a virtual 2026 annual meeting on July 17, 2026 to elect four directors, ratify its auditor and vote on several major share-related proposals. Stockholders are asked to approve an automatic annual increase to the 2020 Stock Incentive Plan, broad authority for future discounted 20% Issuances under Nasdaq rules, and multiple specific share issuances tied to acquisitions and financings.
These include 2,828,167 settlement shares to SecureKloud’s affiliate, up to 11,869,397 shares for the Teyame acquisition, potential issuance of stock above a 405,354-share exchange cap under a $50 million equity line of credit with Hudson Global, and conversion shares for $4.32 million of original issue discount senior secured convertible debentures that could result in up to 9,370,120 new shares. With only 2,027,783 common shares and 20,000 super-voting preferred shares outstanding as of June 8, 2026, these approvals could significantly dilute existing holders and may affect voting control.
Healthcare Triangle, Inc. is asking stockholders to approve a reverse stock split of its common stock at a ratio between 1-for-2 and 1-for-100, with the exact ratio to be chosen later by the Board. The company explains that the main goal is to increase its share price to help maintain compliance with Nasdaq’s $1.00 minimum bid price requirement and reduce the risk of delisting.
The reverse split would reduce the 10,758,725 shares of common stock outstanding as of January 8, 2026 in proportion to the final ratio, without changing each holder’s overall ownership percentage apart from rounding up fractional shares to the next whole share. Authorized common shares would not be reduced, effectively increasing the number available for future issuance. A second proposal asks stockholders to allow adjournment of the special meeting, if needed, to solicit more proxies in support of the reverse split.
Healthcare Triangle, Inc. (HCTI) has called a virtual-only special meeting of stockholders on November 28, 2025 to vote on a single key item. Stockholders are being asked to approve, for purposes of Nasdaq Listing Rule 5635(d), future issuances of the Company’s securities in an aggregate amount of up to $70 million during the period from November 14, 2025 until February 28, 2026, as long as each issuance meets specified Nasdaq parameters.
Nasdaq Rule 5635(d) generally requires stockholder approval when a company issues 20% or more of its common stock (or voting power) in certain non‑public transactions at prices below a defined minimum. Approval of this proposal would satisfy that requirement for qualifying transactions completed within the stated period. The Company notes that any such future issuances under these parameters would have a dilutive effect on existing stockholders’ ownership and voting power over time. Only stockholders of record as of November 12, 2025 are entitled to vote, and the Board unanimously recommends voting “FOR” the proposal.
Healthcare Triangle (HCTI) called its 2025 Annual Meeting for November 7, 2025 at 10:00 a.m. Pacific Time, to be held virtually. Stockholders will vote to elect four directors and to ratify SRCO Professional Corporation as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The Board unanimously recommends voting FOR all nominees and FOR auditor ratification.
Only stockholders of record at the close of business on September 29, 2025 may vote. Registration to attend is required by November 5, 2025 at 11:59 p.m. Eastern Time. Nominees are Dave Rosa, Sujatha Ramesh, Ronald McClurg, and Jainal Bhuiyan.
SRCO has served as auditor since April 2025; prior reports by M&K CPAS, PLLC contained no adverse opinions or modifications. As context, Suresh Venkatachari holds Series A Super Voting Preferred Shares representing 77.11% of voting power as of October 15, 2025. Shares outstanding were 5,873,304 common and 20,000 Series A Super Voting Preferred as of October 15, 2025.